[1] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA:A Cancer Journal for Clinicians, 2021, 71(3): 209 – 249. doi: 10.3322/caac.21660
|
[2] |
Feng RM, Zong YN, Cao SM, et al. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?[J]. Cancer Communications, 2019, 39(1): 1 – 12. doi: 10.1186/s40880-018-0346-4
|
[3] |
张思维, 郑荣寿, 杨之洵, 等. 2000 — 2014年中国肿瘤登记地区肺癌发病年龄变化趋势分析[J]. 中华预防医学杂志, 2018, 52(6): 579 – 585. doi: 10.3760/cma.j.issn.0253-9624.2018.06.005
|
[4] |
郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1): 19 – 28. doi: 10.3760/cma.j.issn.0253-3766.2019.01.005
|
[5] |
蔡玥, 严宝湖, 周恭伟. 2011 — 2015年中国肺癌直接经济负担及次均费用分析[J]. 中国卫生统计, 2018, 35(3): 334 – 337.
|
[6] |
曹毛毛, 陈万青. 坚持政府主导推进中国癌症筛查发展[J]. 中国肿瘤, 2021, 30(11): 803 – 805. doi: 10.11735/j.issn.1004-0242.2021.11.A001
|
[7] |
徐望红. 肿瘤流行病学[M]. 上海: 复旦大学出版社, 2017: 327.
|
[8] |
Rex DK, Johnson DA, Lieberman DA, et al. Colorectal cancer preven-tion 2000: screening recommendations of the American College of Gastroenterology[J]. The American Journal of Gastroenterology, 2000, 95(4): 868 – 877.
|
[9] |
The National Lung Screening Trial Research Team. Reduced lung - cancer mortality with low - dose computed tomographic screening[J]. New England Journal of Medicine, 2011, 365(5): 395 – 409. doi: 10.1056/NEJMoa1102873
|
[10] |
Faivre J, Dancourt V, Lejeune C, et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study[J]. Gastroenterology, 2004, 126(7): 1674 – 1680. doi: 10.1053/j.gastro.2004.02.018
|
[11] |
Oken MM, Hocking WG, Kvale PA, et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Trial[J]. JAMA, 2011, 306(17): 1865 – 1873. doi: 10.1001/jama.2011.1591
|
[12] |
苟兰英, 高红飞, 韩解非, 等. 2013年临床肿瘤学重大进展 —— 美国临床肿瘤学会年度报告[J]. 循证医学, 2014, 14(1): 4 – 29. doi: 10.3969/j.issn.1671-5144.2014.01.002
|
[13] |
de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lung - cancer mortality with volume CT screening in a randomized trial[J]. New England Journal of Medicine, 2020, 382(6): 503 – 513. doi: 10.1056/NEJMoa1911793
|
[14] |
Field JK, Vulkan D, Davies MPA, et al. Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta - analysis[J]. The Lancet Regional Health - Europe, 2021, 10: 100179. doi: 10.1016/j.lanepe.2021.100179
|
[15] |
Zhou QH, Fan YG, Wu N, et al. Demonstration program of population - based lung cancer screening in China: rationale and study design[J]. Thoracic Cancer, 2014, 5(3): 197 – 203. doi: 10.1111/1759-7714.12078
|
[16] |
Zhao SJ, Wu N. Early detection of lung cancer: low - dose computed tomography screening in China[J]. Thoracic Cancer, 2015, 6(4): 385 – 389. doi: 10.1111/1759-7714.12253
|
[17] |
Jemal A, Ward EM, Johnson CJ, et al. Annual report to the nation on the status of cancer, 1975 – 2014, featuring survival[J]. JNCI: Journal of the National Cancer Institute, 2017, 109(9): djx030.
|
[18] |
Sun JR, Perraillon MC, Myerson R. The impact of medicare health insurance coverage on lung cancer screening[J]. Medical Care, 2022, 60(1): 29 – 36. doi: 10.1097/MLR.0000000000001655
|
[19] |
Viguier J, Morère JF, Pivot X, et al. Fluctuating behavior of the French population in cancer screening: 5th edition of the EDIFICE survey[J]. Current Oncology Reports, 2018, 20(S1): 14. doi: 10.1007/s11912-017-0646-x
|
[20] |
Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000 – 14 (CONCORD - 3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries[J]. The Lancet, 2018, 391(10125): 1023 – 1075. doi: 10.1016/S0140-6736(17)33326-3
|
[21] |
Schütte S, Dietrich D, Montet X, et al. Participation in lung cancer screening programs: are there gender and social differences? A systematic review[J]. Public Health Reviews, 2018, 39: 23. doi: 10.1186/s40985-018-0100-0
|
[22] |
Jemal A, Fedewa SA. Lung cancer screening with low - dose computed tomography in the United States – 2010 to 2015[J]. JAMA Oncology, 2017, 3(9): 1278 – 1281. doi: 10.1001/jamaoncol.2016.6416
|
[23] |
Steiling K, Loui T, Asokan S, et al. Age, race, and income are associated with lower screening rates at a safety net hospital[J]. The Annals of Thoracic Surgery, 2020, 109(5): 1544 – 1550. doi: 10.1016/j.athoracsur.2019.11.052
|
[24] |
Rivera MP, Katki HA, Tanner NT, et al. Addressing disparities in lung cancer screening eligibility and healthcare access. an official American thoracic society statement[J]. American Journal of Respiratory and Critical Care Medicine, 2020, 202(7): e95 – e112. doi: 10.1164/rccm.202008-3053ST
|
[25] |
Guichet PL, Liu BY, Desai B, et al. Preliminary results of lung cancer screening in a socioeconomically disadvantaged popula-tion[J]. American Journal of Roentgenology, 2018, 210(3): 489 – 496. doi: 10.2214/AJR.17.18853
|
[26] |
Ali N, Lifford KJ, Carter B, et al. Barriers to uptake among high - risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial[J]. BMJ Open, 2015, 5(7): e008254. doi: 10.1136/bmjopen-2015-008254
|
[27] |
Zeliadt SB, Hoffman RM, Birkby G, et al. Challenges implement-ing lung cancer screening in federally qualified health centers[J]. American Journal of Preventive Medicine, 2018, 54(4): 568 – 575. doi: 10.1016/j.amepre.2018.01.001
|
[28] |
Richmond J, Mbah OM, Dard SZ, et al. Evaluating potential racial inequities in low - dose computed tomography screening for lung cancer[J]. Journal of the National Medical Association, 2020, 112(2): 209 – 214. doi: 10.1016/j.jnma.2019.10.002
|
[29] |
Lake M, Shusted CS, Juon HS, et al. Black patients referred to a lung cancer screening program experience lower rates of screening and longer time to follow - up[J]. BMC Cancer, 2020, 20(1): 561. doi: 10.1186/s12885-020-06923-0
|
[30] |
Li CC, Matthews AK, Rywant MM, et al. Racial disparities in eligibility for low - dose computed tomography lung cancer screening among older adults with a history of smoking[J]. Cancer Causes and Control, 2019, 30(3): 235 – 240. doi: 10.1007/s10552-018-1092-2
|
[31] |
Lin JS, Finlay A, Tu A, et al. Understanding immigrant Chinese Americans' participation in cancer screening and clinical trials[J]. Journal of Community Health, 2005, 30(6): 451 – 466. doi: 10.1007/s10900-005-7280-5
|
[32] |
Barta JA, Shusted CS, Ruane B, et al. Racial differences in lung cancer screening beliefs and screening adherence[J]. Clinical Lung Cancer, 2021, 22(6): 570 – 578. doi: 10.1016/j.cllc.2021.06.003
|
[33] |
Quaife SL, Marlow LAV, McEwen A, et al. Attitudes towards lung cancer screening in socioeconomically deprived and heavy smoking communities: informing screening communication[J]. Health Expectations, 2017, 20(4): 563 – 573. doi: 10.1111/hex.12481
|
[34] |
Huang JX, Yue N, Wu JW, et al. Screening rate and influential factors of lung cancer with low - dose computed tomography in Asian population: a systematic review and meta - analysis[J]. Journal of Public Health, 2022, 44(2): 246 – 254. doi: 10.1093/pubmed/fdaa225
|
[35] |
Wang GX, Baggett TP, Pandharipande PV, et al. Barriers to lung cancer screening engagement from the patient and provider perspective[J]. Radiology, 2019, 290(2): 278 – 287. doi: 10.1148/radiol.2018180212
|
[36] |
Hoffman RM, Sussman AL, Getrich CM, et al. Attitudes and beliefs of primary care providers in new Mexico about lung cancer screening using low - dose computed tomography[J]. Preventing Chronic Disease, 2015, 12: E108.
|
[37] |
Jonnalagadda S, Bergamo C, Lin JJ, et al. Beliefs and attitudes about lung cancer screening among smokers[J]. Lung Cancer, 2012, 77(3): 526 – 531. doi: 10.1016/j.lungcan.2012.05.095
|
[38] |
Carter-Harris L, Slaven II JE, Monahan PO, et al. Understanding lung cancer screening behaviour using path analysis[J]. Journal of Medical Screening, 2020, 27(2): 105 – 112. doi: 10.1177/0969141319876961
|
[39] |
Quaife SL, Waller J, Dickson JL, et al. Psychological targets for lung cancer screening uptake: a prospective longitudinal cohort study[J]. Journal of Thoracic Oncology, 2021, 16(12): 2016 – 2028. doi: 10.1016/j.jtho.2021.07.025
|
[40] |
Patel D, Akporobaro A, Chinyanganya N, et al. Attitudes to participation in a lung cancer screening trial: a qualitative study[J]. Thorax, 2012, 67(5): 418 – 425. doi: 10.1136/thoraxjnl-2011-200055
|
[41] |
Bui NC, Lee YY, Suh M, et al. Beliefs and intentions to undergo lung cancer screening among Korean males[J]. Cancer Research and Treatment, 2018, 50(4): 1096 – 1105. doi: 10.4143/crt.2017.393
|
[42] |
Lei F, Chen WT, Brecht ML, et al. Health beliefs toward lung cancer screening among Chinese American high - risk smokers: interviews based on Health Belief Model[J]. International Journal of Nursing Sciences, 2022, 9(3): 378 – 388. doi: 10.1016/j.ijnss.2022.06.005
|
[43] |
Monu J, Triplette M, Wood DE, et al. Evaluating knowledge, attitudes, and beliefs about lung cancer screening using crowdsourcing[J]. Chest, 2020, 158(1): 386 – 392. doi: 10.1016/j.chest.2019.12.048
|
[44] |
Sin MK, Ha A, Taylor V. Sociocultural barriers to lung cancer screening among Korean immigrant men[J]. Journal of Community Health, 2016, 41(4): 790 – 797. doi: 10.1007/s10900-016-0154-1
|
[45] |
Carter-Harris L, Brandzel S, Wernli KJ, et al. A qualitative study exploring why individuals opt out of lung cancer screening[J]. Family Practice, 2017, 34(2): 239 – 244.
|
[46] |
Springer SM, McFall A, Hager P, et al. Lung cancer screening: an emerging cancer control issue presents opportunities for an awareness campaign in rural Michigan[J]. Cancer Causes and Control, 2018, 29(12): 1257 – 1263. doi: 10.1007/s10552-018-1080-6
|
[47] |
Athey VL, Suckling RJ, Tod AM, et al. Early diagnosis of lung cancer: evaluation of a community - based social marketing intervention[J]. Thorax, 2012, 67(5): 412 – 417. doi: 10.1136/thoraxjnl-2011-200714
|
[48] |
Murray SR, Murchie P, Campbell N, et al. Protocol for the CHEST Australia Trial: a phase II randomised controlled trial of an intervention to reduce time - to - consult with symptoms of lung cancer[J]. BMJ Open, 2015, 5(5): e008046. doi: 10.1136/bmjopen-2015-008046
|
[49] |
Wildstein KA, Faustini Y, Yip R, et al. Longitudinal predictors of adherence to annual follow - up in a lung cancer screening programme[J]. Journal of Medical Screening, 2011, 18(3): 154 – 159. doi: 10.1258/jms.2011.010127
|
[50] |
Liu B, Dharmarajan K, Henschke CI, et al. State - level variations in the utilization of lung cancer screening among Medicare fee - for - service beneficiaries: an analysis of the 2015 to 2017 physician and other supplier data[J]. Chest, 2020, 157(4): 1012 – 1020. doi: 10.1016/j.chest.2019.11.005
|
[51] |
Braybrook DE, Witty KR, Robertson S. Men and lung cancer: a review of the barriers and facilitators to male engagement in symptom reporting and screening[J]. Journal of Men’s Health, 2011, 8(2): 93 – 99. doi: 10.1016/j.jomh.2011.03.002
|
[52] |
Jessup DL, Glover IV M, Daye D, et al. Implementation of digital awareness strategies to engage patients and providers in a lung cancer screening program: retrospective study[J]. Journal of Medical Internet Research, 2018, 20(2): e52. doi: 10.2196/jmir.8932
|
[53] |
Lewis JA, Petty WJ, Tooze JA, et al. Low - dose CT lung cancer screening practices and attitudes among primary care providers at an academic medical center[J]. Cancer Epidemiology, Biomarkers and Prevention, 2015, 24(4): 664 – 670. doi: 10.1158/1055-9965.EPI-14-1241
|
[54] |
Klabunde CN, Marcus PM, Han PKJ, et al. Lung cancer screening practices of primary care physicians: results from a national survey[J]. The Annals of Family Medicine, 2012, 10(2): 102 – 110. doi: 10.1370/afm.1340
|
[55] |
Byrne MM, Lillie SE, Studts JL. Lung cancer screening in a community setting: characteristics, motivations, and attitudes of individuals being screened[J]. Health Psychology Open, 2019, 6(1): 2055102918819163.
|
[56] |
Ersek JL, Eberth JM, McDonnell KK, et al. Knowledge of, attitudes toward, and use of low - dose computed tomography for lung cancer screening among family physicians[J]. Cancer, 2016, 122(15): 2324 – 2331. doi: 10.1002/cncr.29944
|
[57] |
Carter-Harris L, Gould MK. Multilevel barriers to the successful implementation of lung cancer screening: why does it have to be so hard?[J]. Annals of the American Thoracic Society, 2017, 14(8): 1261 – 1265. doi: 10.1513/AnnalsATS.201703-204PS
|
[58] |
Iaccarino JM, Clark J, Bolton R, et al. A national survey of pulmonologists' views on low - dose computed tomography screening for lung cancer[J]. Annals of the American Thoracic Society, 2015, 12(11): 1667 – 1675.
|
[59] |
Eberth JM, Qiu R, Adams SA, et al. Lung cancer screening using low - dose CT: the current national landscape[J]. Lung Cancer, 2014, 85(3): 379 – 384. doi: 10.1016/j.lungcan.2014.07.002
|
[60] |
陈万青, 李霓, 曹毛毛, 等. 2013 — 2017年中国城市癌症早诊早治项目基线结果分析[J]. 中国肿瘤, 2020, 29(1): 1 – 6.
|
[61] |
雷锐娇, 张美珍, 王乐, 等. 2014 — 2018年浙江省衢州市城市癌症早诊早治项目筛查结果分析[J]. 中国癌症防治杂志, 2021, 13(6): 618 – 623. doi: 10.3969/j.issn.1674-5671.2021.06.08
|
[62] |
林艳苹, 马洁, 封俊, 等. 云南省昆明市城市居民肺癌筛查结果分析[J]. 中国肺癌杂志, 2019, 22(7): 413 – 418. doi: 10.3779/j.issn.1009-3419.2019.07.02
|
[63] |
汪雯, 李辉章, 朱陈, 等. 浙江省2014 — 2015年度居民癌症风险评估及筛查结果分析[J]. 浙江医学, 2016, 38(22): 1795 – 1798, 1814.
|
[64] |
魏东华, 马艳玲, 张娟, 等. 2014 — 2016年合肥市城市居民肺癌筛查率及筛查结果分析[J]. 实用肿瘤学杂志, 2021, 35(3): 231 – 236. doi: 10.11904/j.issn.1002-3070.2021.03.007
|
[65] |
于志福, 王晓煜, 何嵘, 等. 2012 — 2017年辽宁地区城市居民肺癌筛查结果分析[J]. 现代预防医学, 2020, 47(13): 2442 – 2445, 2470.
|
[66] |
郭兰伟, 张韶凯, 刘曙正, 等. 河南省城市地区低剂量螺旋CT肺癌筛查依从性及其影响因素分析[J]. 中华流行病学杂志, 2020, 41(7): 1076 – 1080. doi: 10.3760/cma.j.cn112338-20190730-00564
|
[67] |
温艳, 于连政, 杜灵彬, 等. 中国3省城市癌症早诊早治项目地区肺癌高危人群的低剂量螺旋CT筛查依从性及相关因素分析[J]. 中华预防医学杂志, 2021, 55(5): 633 – 639. doi: 10.3760/cma.j.cn112150-20201015-01286
|
[68] |
任冠华, 叶剑飞, 范亚光, 等. 中国天津大港油田LDCT肺癌筛查人群防治知识调查与分析[J]. 中国肺癌杂志, 2014, 17(2): 163 – 170.
|
[69] |
毛阿燕, 石菊芳, 邱五七, 等. 我国城市地区癌症临床筛查服务潜在供方服务意愿调查[J]. 中华流行病学杂志, 2018, 39(2): 150 – 156. doi: 10.3760/cma.j.issn.0254-6450.2018.02.004
|